BICO Group AB (publ) (BICO.ST)
SEK 34.84
(5.07%)
SEK 34.84
(5.07%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2022 | 2.23 Billion SEK | 78.12% |
| 2021 | 1.25 Billion SEK | 611.17% |
| 2020 | 176.79 Million SEK | 67.64% |
| 2019 | 105.45 Million SEK | 132.61% |
| 2018 | 45.33 Million SEK | 243.77% |
| 2017 | 13.18 Million SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q2 | 541.1 Million SEK | 8.07% |
| 2023 Q3 | 587.2 Million SEK | 8.52% |
| 2023 Q1 | 500.7 Million SEK | -25.72% |
| 2022 Q3 | 550.6 Million SEK | 2.42% |
| 2022 Q2 | 537.6 Million SEK | 12.66% |
| 2022 Q1 | 477.2 Million SEK | -8.07% |
| 2022 FY | 2.23 Billion SEK | 78.12% |
| 2022 Q4 | 674.1 Million SEK | 22.43% |
| 2021 FY | 1.25 Billion SEK | 611.17% |
| 2021 Q2 | 293.1 Million SEK | 126.33% |
| 2021 Q3 | 315.6 Million SEK | 7.68% |
| 2021 Q4 | 519.1 Million SEK | 64.48% |
| 2021 Q1 | 129.5 Million SEK | 0.0% |
| 2020 Q1 | 37.24 Million SEK | -19.79% |
| 2020 FY | 176.79 Million SEK | 67.64% |
| 2020 Q2 | 41.6 Million SEK | 11.71% |
| 2020 Q3 | 51.51 Million SEK | 23.83% |
| 2019 Q1 | 23.83 Million SEK | 19.36% |
| 2019 FY | 105.45 Million SEK | 132.61% |
| 2019 Q2 | 29.62 Million SEK | 24.28% |
| 2019 Q4 | 46.43 Million SEK | 45.11% |
| 2019 Q3 | 31.99 Million SEK | 8.01% |
| 2018 Q4 | 19.97 Million SEK | 19.72% |
| 2018 FY | 45.33 Million SEK | 243.77% |
| 2018 Q1 | 8.68 Million SEK | 18.02% |
| 2018 Q2 | 12.2 Million SEK | 40.43% |
| 2018 Q3 | 16.68 Million SEK | 36.71% |
| 2017 Q2 | 3.31 Million SEK | 13.12% |
| 2017 FY | 13.18 Million SEK | 0.0% |
| 2017 Q1 | 2.92 Million SEK | 16.32% |
| 2017 Q4 | 7.36 Million SEK | 65.89% |
| 2017 Q3 | 4.43 Million SEK | 34.08% |
| 2016 Q4 | 2.51 Million SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acarix AB (publ) | 6.24 Million SEK | -35783.672% |
| ADDvise Group AB (publ) | 1.37 Billion SEK | -63.11% |
| ADDvise Group AB (publ) | 1.37 Billion SEK | -63.11% |
| Arcoma AB | 163.01 Million SEK | -1273.8% |
| Bactiguard Holding AB (publ) | 203.99 Million SEK | -997.848% |
| Boule Diagnostics AB (publ) | 571.32 Million SEK | -291.981% |
| CellaVision AB (publ) | 677.29 Million SEK | -230.655% |
| Clinical Laserthermia Systems AB (publ) | 8.27 Million SEK | -26969.987% |
| Chordate Medical Holding AB (publ) | 976.28 Thousand SEK | -229290.923% |
| C-Rad AB (publ) | 424.61 Million SEK | -427.419% |
| Duearity AB (publ) | 1.65 Million SEK | -135299.033% |
| Dignitana AB (publ) | 86.06 Million SEK | -2502.164% |
| Episurf Medical AB (publ) | 10.3 Million SEK | -21642.718% |
| Getinge AB (publ) | 31.82 Billion SEK | 92.964% |
| Scandinavian Real Heart AB (Publ) | - SEK | -Infinity% |
| Iconovo AB (publ) | 7.07 Million SEK | -31539.006% |
| Integrum AB (publ) | 104.11 Million SEK | -2050.912% |
| Luxbright AB (publ) | 854.69 Thousand SEK | -261922.069% |
| Mentice AB (publ) | 273.61 Million SEK | -718.501% |
| OssDsign AB (publ) | 112.15 Million SEK | -1896.755% |
| Paxman AB (publ) | 210.11 Million SEK | -965.835% |
| Promimic AB (publ) | 37.07 Million SEK | -5941.273% |
| Qlife Holding AB (publ) | 244 Thousand SEK | -917727.869% |
| SciBase Holding AB (publ) | 23.24 Million SEK | -9534.33% |
| ScandiDos AB (publ) | 60.42 Million SEK | -3606.002% |
| Sectra AB (publ) | 2.96 Billion SEK | 24.433% |
| Sedana Medical AB (publ) | 153.86 Million SEK | -1355.478% |
| Senzime AB (publ) | 35.75 Million SEK | -6163.635% |
| SpectraCure AB (publ) | 318 Thousand SEK | -704145.283% |
| Stille AB | 294.89 Million SEK | -659.428% |
| Vitrolife AB (publ) | 3.51 Billion SEK | 36.233% |
| Xvivo Perfusion AB (publ) | 597.54 Million SEK | -274.785% |